Merck shares slip as Keytruda fails another clinical trial - MarketWatch

in dlike •  6 years ago 

Shared From Dlike

Merck & Co. shares slipped in the extended session Monday after the drug maker said its cancer treatment Keytruda failed to meet clinical endpoints in...


Source of shared Link

dlike dlike-news
6 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
  • Max accepted payout: $900.00
3 votes
0
Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!